Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile
- PMID: 24240933
- PMCID: PMC4226221
- DOI: 10.1001/jama.2013.280532
Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile
Abstract
Importance: In clinical and research settings worldwide, low-density lipoprotein cholesterol (LDL-C) is typically estimated using the Friedewald equation. This equation assumes a fixed factor of 5 for the ratio of triglycerides to very low-density lipoprotein cholesterol (TG:VLDL-C); however, the actual TG:VLDL-C ratio varies significantly across the range of triglyceride and cholesterol levels.
Objective: To derive and validate a more accurate method for LDL-C estimation from the standard lipid profile using an adjustable factor for the TG:VLDL-C ratio.
Design, setting, and participants: We used a convenience sample of consecutive clinical lipid profiles obtained from 2009 through 2011 from 1,350,908 children, adolescents, and adults in the United States. Cholesterol concentrations were directly measured after vertical spin density-gradient ultracentrifugation, and triglycerides were directly measured. Lipid distributions closely matched the population-based National Health and Nutrition Examination Survey (NHANES). Samples were randomly assigned to derivation (n = 900,605) and validation (n = 450,303) data sets.
Main outcomes and measures: Individual patient-level concordance in clinical practice guideline LDL-C risk classification using estimated vs directly measured LDL-C (LDL-CD).
Results: In the derivation data set, the median TG:VLDL-C was 5.2 (IQR, 4.5-6.0). The triglyceride and non-high-density lipoprotein cholesterol (HDL-C) levels explained 65% of the variance in the TG:VLDL-C ratio. Based on strata of triglyceride and non-HDL-C values, a 180-cell table of median TG:VLDL-C values was derived and applied in the validation data set to estimate the novel LDL-C (LDL-CN). For patients with triglycerides lower than 400 mg/dL, overall concordance in guideline risk classification with LDL-CD was 91.7% (95% CI, 91.6%-91.8%) for LDL-CN vs 85.4% (95% CI, 85.3%-85.5%) for Friedewald LDL-C (LDL-CF) (P < .001). The greatest improvement in concordance occurred in classifying LDL-C lower than 70 mg/dL, especially in patients with high triglyceride levels. In patients with an estimated LDL-C lower than 70 mg/dL, LDL-CD was also lower than 70 mg/dL in 94.3% (95% CI, 93.9%-94.7%) for LDL-CN vs 79.9% (95% CI, 79.3%-80.4%) for LDL-CF in samples with triglyceride levels of 100 to 149 mg/dL; 92.4% (95% CI, 91.7%-93.1%) for LDL-CN vs 61.3% (95% CI, 60.3%-62.3%) for LDL-CF in samples with triglyceride levels of 150 to 199 mg/dL; and 84.0% (95% CI, 82.9%-85.1%) for LDL-CN vs 40.3% (95% CI, 39.4%-41.3%) for LDL-CF in samples with triglyceride levels of 200 to 399 mg/dL (P < .001 for each comparison).
Conclusions and relevance: A novel method to estimate LDL-C using an adjustable factor for the TG:VLDL-C ratio provided more accurate guideline risk classification than the Friedewald equation. These findings require external validation, as well as assessment of their clinical importance. The implementation of these findings into clinical practice would be straightforward and at virtually no cost.
Trial registration: clinicaltrials.gov Identifier: NCT01698489.
Conflict of interest statement
Figures
Comment in
-
What's new with measuring cholesterol?JAMA. 2013 Nov 20;310(19):2043-4. doi: 10.1001/jama.2013.282775. JAMA. 2013. PMID: 24240929 No abstract available.
-
[What are the advantages of the modified Friedewald equation?--Modified Friedwald equation measures LDL-cholesterol more exactly].Dtsch Med Wochenschr. 2014 Jan;139(5):180. doi: 10.1055/s-0033-1353887. Epub 2014 Jan 21. Dtsch Med Wochenschr. 2014. PMID: 24449350 German. No abstract available.
Similar articles
-
Comparison of Low-Density Lipoprotein Cholesterol Assessment by Martin/Hopkins Estimation, Friedewald Estimation, and Preparative Ultracentrifugation: Insights From the FOURIER Trial.JAMA Cardiol. 2018 Aug 1;3(8):749-753. doi: 10.1001/jamacardio.2018.1533. JAMA Cardiol. 2018. PMID: 29898218 Free PMC article.
-
Comparison of Methods to Estimate Low-Density Lipoprotein Cholesterol in Patients With High Triglyceride Levels.JAMA Netw Open. 2021 Oct 1;4(10):e2128817. doi: 10.1001/jamanetworkopen.2021.28817. JAMA Netw Open. 2021. PMID: 34709388 Free PMC article.
-
Validation of the Martin Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Korean Adults: Findings from the Korea National Health and Nutrition Examination Survey, 2009-2011.PLoS One. 2016 Jan 29;11(1):e0148147. doi: 10.1371/journal.pone.0148147. eCollection 2016. PLoS One. 2016. PMID: 26824910 Free PMC article.
-
Update on low-density lipoprotein cholesterol quantification.Curr Opin Lipidol. 2019 Aug;30(4):273-283. doi: 10.1097/MOL.0000000000000611. Curr Opin Lipidol. 2019. PMID: 31135594 Review.
-
Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.Am J Cardiol. 1998 Feb 26;81(4A):26B-31B. doi: 10.1016/s0002-9149(98)00034-4. Am J Cardiol. 1998. PMID: 9526810 Review.
Cited by
-
Chinese expert consensus on blood lipid management in patients with diabetes (2024 edition).J Transl Int Med. 2024 Oct 1;12(4):325-343. doi: 10.2478/jtim-2024-0014. eCollection 2024 Sep. J Transl Int Med. 2024. PMID: 39360162 Free PMC article.
-
Comparison of Multiple Equations for Low-Density Lipoprotein Cholesterol Calculation Against the Direct Homogeneous Method.J Lipid Atheroscler. 2024 Sep;13(3):348-357. doi: 10.12997/jla.2024.13.3.348. Epub 2024 Jul 15. J Lipid Atheroscler. 2024. PMID: 39355402 Free PMC article.
-
Assessing Performance of Martins's and Sampson's Formulae for Calculation of LDL-C in Indian Population: A Single Center Retrospective Study.Indian J Clin Biochem. 2024 Oct;39(4):579-585. doi: 10.1007/s12291-023-01142-3. Epub 2023 Jul 7. Indian J Clin Biochem. 2024. PMID: 39346721
-
Low-Density Lipoprotein Cholesterol Gymnastics: Exploring the Advantages and Limitations of the Friedewald, Martin-Hopkins, and Sampson Equations for Personalized Lipid Management.J Pers Med. 2024 Sep 20;14(9):1000. doi: 10.3390/jpm14091000. J Pers Med. 2024. PMID: 39338254 Free PMC article.
-
Phenotyping lipid profiles in type 2 diabetes: Risk association and outcomes from the Cardiovascular Health Study.Am J Prev Cardiol. 2024 Aug 26;19:100725. doi: 10.1016/j.ajpc.2024.100725. eCollection 2024 Sep. Am J Prev Cardiol. 2024. PMID: 39286650 Free PMC article.
References
-
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502. - PubMed
-
- DeLong DM, DeLong ER, Wood PD, Lippel K, Rifkind BM. A comparison of methods for the estimation of plasma low- and very low-density lipoprotein cholesterol: the Lipid Research Clinics Prevalence Study. JAMA. 1986;256(17):2372–2377. - PubMed
-
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA. 2001;285(19):2486–2497. - PubMed
-
- National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421. - PubMed
-
- Grundy SM, Cleeman JI, Merz CN, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110(2):227–239. - PubMed
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
